Image
Portfolio

Growth/Buyout Portfolio - OriGene

ORIGENE

Key figures
  • 1996
    Creation Date
  • 2015
    Investment Date
  • 2016
    Exit Date
  • Mérieux Participations 2
    Fund Name
Company presentation

OriGene Technologies is a research tool company commercializing products and services in the life science and clinical diagnostic segments, in the US, China and Europe. It currently owns the largest commercial collection of full-length human cDNAs in a standard expression vector.

OriGene's vision is to enable scientists and clinicians to study complete biological pathways, thus allowing a better understanding of disease mechanisms including in cancer and stem cell research.

Exit Date: 2016

Location

9620 Medical Center Dr. - Suite 200 - MD 20850 Rockville - USA